NM_001101426.4:c.*3283G>A

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001101426.4(CRPPA):​c.*3283G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0084 ( 8 hom., cov: 16)
Failed GnomAD Quality Control

Consequence

CRPPA
NM_001101426.4 3_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.05

Publications

0 publications found
Variant links:
Genes affected
CRPPA (HGNC:37276): (CDP-L-ribitol pyrophosphorylase A) This gene encodes a 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase-like protein. Mutations in this gene are the cause of Walker-Warburg syndrome. Alternate splicing results in multiple transcript variants. [provided by RefSeq, May 2012]
CRPPA Gene-Disease associations (from GenCC):
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • myopathy caused by variation in CRPPA
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal recessive limb-girdle muscular dystrophy type 2U
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00845 (956/113142) while in subpopulation AMR AF = 0.0115 (109/9504). AF 95% confidence interval is 0.0107. There are 8 homozygotes in GnomAd4. There are 415 alleles in the male GnomAd4 subpopulation. Median coverage is 16. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 8 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRPPANM_001101426.4 linkc.*3283G>A 3_prime_UTR_variant Exon 10 of 10 ENST00000407010.7 NP_001094896.1 A4D126-1
CRPPANR_160656.1 linkn.4704G>A non_coding_transcript_exon_variant Exon 8 of 8
CRPPANM_001368197.1 linkc.*3283G>A 3_prime_UTR_variant Exon 9 of 9 NP_001355126.1
CRPPANM_001101417.4 linkc.*3283G>A 3_prime_UTR_variant Exon 9 of 9 NP_001094887.1 A4D126-2A0A140VJM1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRPPAENST00000407010.7 linkc.*3283G>A 3_prime_UTR_variant Exon 10 of 10 5 NM_001101426.4 ENSP00000385478.2 A4D126-1

Frequencies

GnomAD3 genomes
AF:
0.00844
AC:
955
AN:
113150
Hom.:
8
Cov.:
16
show subpopulations
Gnomad AFR
AF:
0.00261
Gnomad AMI
AF:
0.0631
Gnomad AMR
AF:
0.0115
Gnomad ASJ
AF:
0.00102
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00365
Gnomad FIN
AF:
0.00424
Gnomad MID
AF:
0.0220
Gnomad NFE
AF:
0.0114
Gnomad OTH
AF:
0.0123
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AC:
0
AN:
0
Hom.:
0
Cov.:
0
AC XY:
0
AN XY:
0
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AC:
0
AN:
0
GnomAD4 genome
AF:
0.00845
AC:
956
AN:
113142
Hom.:
8
Cov.:
16
AF XY:
0.00790
AC XY:
415
AN XY:
52530
show subpopulations
African (AFR)
AF:
0.00264
AC:
73
AN:
27660
American (AMR)
AF:
0.0115
AC:
109
AN:
9504
Ashkenazi Jewish (ASJ)
AF:
0.00102
AC:
3
AN:
2936
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3686
South Asian (SAS)
AF:
0.00367
AC:
14
AN:
3810
European-Finnish (FIN)
AF:
0.00424
AC:
19
AN:
4478
Middle Eastern (MID)
AF:
0.0230
AC:
4
AN:
174
European-Non Finnish (NFE)
AF:
0.0114
AC:
666
AN:
58564
Other (OTH)
AF:
0.0122
AC:
19
AN:
1554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.594
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00145
Hom.:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Congenital Muscular Dystrophy, alpha-dystroglycan related Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.41
DANN
Benign
0.86
PhyloP100
-1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs370712733; hg19: chr7-16128037; API